Online citations, reference lists, and bibliographies.
← Back to Search

Oxidative Modification Of Peroxiredoxin Is Associated With Drug-induced Apoptotic Signaling In Experimental Models Of Parkinson Disease*

Young Mook Lee, S. Park, Dong-ik Shin, Jee-Yeon Hwang, Bokyung Park, Yun-jong Park, T. Lee, H. Chae, B. Jin, T. Oh, Y. Oh
Published 2008 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The aim of this study was to investigate changes in protein profiles during the early phase of dopaminergic neuronal death using two-dimensional gel electrophoresis in conjunction with mass spectrometry. Several protein spots were identified whose expression was significantly altered following treatment of MN9D dopaminergic neuronal cells with 6-hydroxydopamine (6-OHDA). In particular, we detected oxidative modification of thioredoxin-dependent peroxidases (peroxiredoxins; PRX) in treated MN9D cells. Oxidative modification of PRX induced by 6-OHDA was blocked in the presence of N-acetylcysteine, suggesting that reactive oxygen species (ROS) generated by 6-OHDA induce oxidation of PRX. These findings were confirmed in primary cultures of mesencephalic neurons and in rat brain injected stereotaxically. Overexpression of PRX1 in MN9D cells (MN9D/PRX1) exerted neuroprotective effects against death induced by 6-OHDA through scavenging of ROS. Consequently, generation of both superoxide anion and hydrogen peroxide following 6-OHDA treatment was decreased in MN9D/PRX1. Furthermore, overexpression of PRX1 protected cells against 6-OHDA-induced activation of p38 MAPK and subsequent activation of caspase-3. In contrast, 6-OHDA-induced apoptotic death signals were enhanced by RNA interference-targeted reduction of PRX1 in MN9D cells. Taken together, our data suggest that the redox state of PRX may be intimately involved in 6-OHDA-induced dopaminergic neuronal cell death and also provide a molecular mechanism by which PRX1 exerts a protective role in experimental models of Parkinson disease.
This paper references
10.1001/ARCHNEUR.1975.00490440064010
Brain peroxidase and catalase in Parkinson disease.
L. Ambani (1975)
Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.
D. Graham (1978)
10.1073/PNAS.76.1.514
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
J. Bottenstein (1979)
10.1016/S0166-2236(84)80278-7
The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5
Larry W. Swanson (1984)
10.1016/0304-3940(85)90078-3
Glutathione peroxidase activity in Parkinson's disease brain
S. Kish (1985)
10.1016/0140-6736(90)91099-V
Superoxide dismutase and Parkinson's disease
I. Ceballos (1990)
10.1111/j.1471-4159.1991.tb11444.x
The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine Neurons
D. Ben-Shachar (1991)
10.1016/0006-8993(91)90661-E
Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion
Hyung K. Choi (1991)
10.1073/PNAS.89.19.8943
Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions.
H. Choi (1992)
10.1016/0304-3940(92)90355-B
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease
E. Sofić (1992)
10.1002/ANA.410320616
The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it
S. Fahn (1992)
10.1016/0960-9822(93)90195-T
Rapid identification of proteins by peptide-mass fingerprinting
D. Pappin (1993)
Cloning, sequencing, and mutation of thiol-specific antioxidant gene of Saccharomyces cerevisiae.
H. Z. Chae (1993)
10.1016/0306-4522(93)90175-F
Glutathione peroxidase, glial cells and Parkinson's disease
P. Damier (1993)
10.1073/PNAS.91.15.7017
Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes.
H. Z. Chae (1994)
10.1006/nbdi.1995.0017
Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line
Y. Oh (1995)
10.1038/26652
The ubiquitin pathway in Parkinson's disease
E. Leroy (1998)
10.1046/j.1471-4159.1998.70010268.x
Increased Protein Oxidation in Human Substantia Nigra Pars Compacta in Comparison with Basal Ganglia and Prefrontal Cortex Measured with an Improved Dinitrophenylhydrazine Assay
E. Floor (1998)
The Rat Brain
G. Paxinos (1998)
10.1523/JNEUROSCI.19-04-01284.1999
Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons
Julie Lotharius (1999)
10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO;2-E
Two distinct mechanisms are involved in 6‐hydroxydopamine‐ and MPP+‐induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK
Won‐Seok Choi (1999)
10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR10>3.0.CO;2-X
Differential expression of peroxiredoxin subtypes in human brain cell types.
T. Sarafian (1999)
10.1016/S0168-8227(99)00037-6
Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin.
H. Chae (1999)
10.1021/BI992025K
Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation.
A. Claiborne (1999)
10.1006/BBRC.2000.2231
Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis.
Y. Zhou (2000)
10.1016/S0304-3940(00)00910-1
Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system
H. Mizusawa (2000)
10.1126/SCIENCE.290.5493.985
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
B. Giasson (2000)
Causes of neuronal death in Parkinson's disease.
A. Schapira (2001)
10.1006/BBRC.2001.5989
Augmented expression of peroxiredoxin I in lung cancer.
J. Chang (2001)
10.1080/10715760100300831
Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat
A. Mitsumoto (2001)
10.1074/JBC.M106585200
Proteomics Analysis of Cellular Response to Oxidative Stress
T. Rabilloud (2002)
10.1074/jbc.M204222200
An Antisense Oligonucleotide to 1-cys Peroxiredoxin Causes Lipid Peroxidation and Apoptosis in Lung Epithelial Cells*
J. Pak (2002)
10.1179/135100002125000352
Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein
J. Fujii (2002)
10.1074/JBC.M206626200
Inactivation of Human Peroxiredoxin I during Catalysis as the Result of the Oxidation of the Catalytic Site Cysteine to Cysteine-sulfinic Acid*
Kap-Seok Yang (2002)
10.1523/JNEUROSCI.23-13-05877.2003
Thrombin-Induced Microglial Activation Produces Degeneration of Nigral Dopaminergic Neurons In Vivo
Sang-H Choi (2003)
10.1523/JNEUROSCI.23-12-05069.2003
Caspase-Dependent and -Independent Cell Death Pathways in Primary Cultures of Mesencephalic Dopaminergic Neurons after Neurotoxin Treatment
B. Han (2003)
10.1016/S0968-0004(02)00003-8
Structure, mechanism and regulation of peroxiredoxins.
Z. Wood (2003)
10.1016/S0304-3940(03)00173-3
A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau
B. S. Han (2003)
10.1074/JBC.M209915200
Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways*
S. Allen (2003)
10.1016/S0891-5849(02)01440-5
Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice.
F. Plaisant (2003)
10.1046/j.1471-4159.2003.01918.x
Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo
F. Hattori (2003)
10.1038/nature02075
ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin
B. Biteau (2003)
10.1016/S0896-6273(03)00568-3
Parkinson's Disease Mechanisms and Models
W. Dauer (2003)
10.1126/SCIENCE.1080273
Reversing the Inactivation of Peroxiredoxins Caused by Cysteine Sulfinic Acid Formation
H. A. Woo (2003)
10.1074/jbc.C300428200
Reversible Oxidation of the Active Site Cysteine of Peroxiredoxins to Cysteine Sulfinic Acid
H. Woo (2003)
10.1016/S0006-8993(02)04243-9
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
K. Krapfenbauer (2003)
10.1007/s00018-003-3048-1
Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is underexpressed in Down syndrome fetal brains
M. F. Sánchez-Font (2003)
10.1074/jbc.M305161200
Regeneration of Peroxiredoxins during Recovery after Oxidative Stress
M. Chevallet (2003)
Free Radic
F Plaisant (2003)
10.1074/JBC.M311164200
Phosphorylation of p38 MAPK Induced by Oxidative Stress Is Linked to Activation of Both Caspase-8- and -9-mediated Apoptotic Pathways in Dopaminergic Neurons*
Wonseok Choi (2004)
10.1016/S0002-9440(10)63426-8
Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis.
Christoph W. Strey (2004)
10.1016/J.BBAMCR.2004.04.006
Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress.
J. Yuan (2004)
10.1074/jbc.M307698200
Cytosolic Peroxiredoxin Attenuates The Activation Of Jnk And P38 But Potentiates That Of Erk In Hela Cells Stimulated With Tumor Necrosis Factor-α*
S. W. Kang (2004)
10.1074/jbc.M314124200
Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases*
Joungil Choi (2004)
10.1016/J.MOLCEL.2004.06.021
A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase.
E. Veal (2004)
10.1146/ANNUREV.NEURO.28.061604.135718
Molecular pathophysiology of Parkinson's disease.
D. Moore (2005)
10.1074/jbc.M502757200
Oxidation of a Eukaryotic 2-Cys Peroxiredoxin Is a Molecular Switch Controlling the Transcriptional Response to Increasing Levels of Hydrogen Peroxide*
Stephanie M. Bozonet (2005)
10.1038/nm1314
Dopamine covalently modifies and functionally inactivates parkin
M. Lavoie (2005)
10.1016/J.BIOPHA.2005.07.003
Sulfiredoxin: a potential therapeutic agent?
V. Findlay (2005)
10.1016/J.ABB.2004.06.016
Redox control of catalytic activities of membrane-associated protein tyrosine kinases.
I. Nakashima (2005)
10.1038/sj.cdd.4401625
The thioredoxin system in retroviral infection and apoptosis
H. Masutani (2005)
10.1074/JBC.M414327200
Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases*
Joungil Choi (2005)
10.1016/j.cell.2005.02.001
Mitochondria, Oxidants, and Aging
R. Balaban (2005)
10.1158/0008-5472.CAN-04-1754
PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.
Z. Liu (2005)
10.1016/J.FREERADBIOMED.2005.02.026
Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.
S. Rhee (2005)
10.1016/j.neulet.2005.02.048
Characterization of neural cell types expressing peroxiredoxins in mouse brain
Mei-hua Jin (2005)
Free Radic
S G Rhee (2005)
10.1074/jbc.M605026200
Dual Role of Peroxiredoxin I in Macrophage-derived Foam Cells*
J. P. Conway (2006)
10.1158/0008-5472.CAN-05-4446
Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex.
Yun-Jeong Kim (2006)
10.1074/jbc.M509079200
Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases*
Joungil Choi (2006)
10.1016/J.FREERADBIOMED.2006.12.004
Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action.
Yoshiro Saito (2007)
10.1385/MN:29:3:229
Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection
H. Masutani (2007)
10.1089/ARS.2006.1513
Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine?
J. Bai (2007)
10.1016/j.neuron.2007.05.033
Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease
Dianbo Qu (2007)
Free Radic
Y Saito (2007)



This paper is referenced by
10.3390/cells10010076
Identification of Targets from LRRK2 Rescue Phenotypes
Joanne Toh (2021)
10.1016/j.neuroscience.2020.11.006
Proteomic Complexity in Parkinson’s Disease: A Redox Signaling Perspective of the Pathophysiology and Progression
M. Martinez-Banaclocha (2021)
10.1016/j.bbrc.2021.02.045
Dysregulated autophagy is linked to BAX oligomerization and subsequent cytochrome c release in 6-hydroxydopmaine-treated neuronal cells.
Yuhyun Chung (2021)
10.3390/cells9020315
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease
F. Teixeira (2020)
10.3390/antiox9121203
Peroxiredoxins in Neurodegenerative Diseases
M. Szeliga (2020)
10.5114/aoms.2020.93121
Protective effect of hydrogen sulfide is mediated by negative regulation of epigenetic histone acetylation in Parkinson’s disease
Yang Sun (2020)
10.1038/s41419-020-03145-x
RING-finger protein 166 plays a novel pro-apoptotic role in neurotoxin-induced neurodegeneration via ubiquitination of XIAP
Chang-Ki Oh (2020)
10.1016/j.redox.2020.101695
α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo
Victor S. Van Laar (2020)
10.18632/aging.103843
Chetomin rescues pathogenic phenotype of LRRK2 mutation in drosophila
L. Chua (2020)
10.1016/j.bbrc.2019.09.089
Anamorsin attenuates cupric chloride-induced dopaminergic neuronal cell death.
Kyung-Ah Park (2019)
10.1186/s12967-019-2076-z
Plasma peroxiredoxin changes and inflammatory cytokines support the involvement of neuro-inflammation and oxidative stress in Autism Spectrum Disorder
P. Abruzzo (2019)
10.1016/j.brainres.2019.146615
The neural stem cell secretome and its role in brain repair
Cory M Willis (2019)
10.1007/s12035-019-01654-1
Autophagy Stimulation Decreases Dopaminergic Neuronal Death Mediated by Oxidative Stress
Marcela J. Ramirez-Moreno (2019)
10.1055/s-0044-101467
DNA Methylation Profiling in a Neuroblastoma Cell Line Exposed to the Antipsychotic Perospirone.
Y. Murata (2019)
10.3390/cells9010022
Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis
Mei-Jen Wang (2019)
10.1002/sctm.18-0009
Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease
B. Mendes-Pinheiro (2018)
10.1038/s41419-018-1229-y
Dysregulated autophagy contributes to caspase-dependent neuronal apoptosis
Yuhyun Chung (2018)
Title Thiol redox homeostasis in neurodegenerative disease
G. McBean (2018)
Metabolic Disorder Dysfunction in Parkinson ’ s Disease : Bioenergetics , Redox Homeostasis and Central Carbon Metabolism
A. Anandhan (2017)
10.1016/j.brainresbull.2017.03.009
Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
A. Anandhan (2017)
10.2174/1874205X01711010048
Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer’s Disease
L.E. Henderson (2017)
10.1016/j.pharmthera.2016.03.018
Roles of peroxiredoxins in cancer, neurodegenerative diseases and inflammatory diseases
M. H. Park (2016)
10.1089/SCD.2016.0048
Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis
O. PiresAna (2016)
10.1089/scd.2016.0048
Unveiling the Differences of Secretome of Human Bone Marrow Mesenchymal Stem Cells, Adipose Tissue-Derived Stem Cells, and Human Umbilical Cord Perivascular Cells: A Proteomic Analysis.
A. O. Pires (2016)
10.1016/j.redox.2015.04.004
Thiol redox homeostasis in neurodegenerative disease
G. McBean (2015)
10.3892/mmr.2015.4400
Luteolin-induced protection of H₂O₂-induced apoptosis in PC12 cells and the associated pathway.
P. Lin (2015)
10.3892/OL.2015.3424
Peroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakia.
M. Zhang (2015)
10.1007/978-94-007-7920-4_4
Amide-type adduct of dopamine - plausible cause of Parkinson diseases.
X. Liu (2014)
10.5607/en.2014.23.1.65
Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment
Dong-ik Shin (2014)
10.1155/2014/715867
2-Cys Peroxiredoxins: Emerging Hubs Determining Redox Dependency of Mammalian Signaling Networks
J. Park (2014)
10.1089/rej.2013.1473
Morphine protects SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cell damage: involvement of anti-oxidant, calcium blocking, and anti-apoptotic properties.
L. Elyasi (2014)
10.1016/B978-0-12-802215-3.00008-2
Curcumin: A Potent Modulator of Multiple Enzymes in Multiple Cancers.
A. Shehzad (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar